Clinical trial

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

NCT03881449

Study summary

ClinicalTrials.gov

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

COMBINATION_PRODUCT · Unmapped registry intervention ABILIFY MYCITE Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-04-04

PhasePHASE4

Conditions

Schizophreniaverified · MONDO: schizophrenia

Major Depressive Disorderverified · MONDO: major depressive disorder

Bi-Polar Disorderunresolved

Schizo Affective Disorderunresolved

Interventions

ABILIFY MYCITECOMBINATION_PRODUCT

Sponsors & collaborators

Durham VA Medical Centerlead sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.collaborator

Mapped research locations

HoustonTexas, United States1 DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03881449 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.